Dr. Denis Bedoret serves as President of Masthercell Global of the Company.A. of the Company. Dr. Bedoret has served as the General Manager of MaSTherCell since his appointment on July 6, 2017. Dr. Bedoret joined MaSTherCell in October 2016 as Chief Business and Administration Officer. Prior to joining MaSTherCell, from January 2014 to September 2016, he held the position of Chief Operations Officer at Quality Assistance, a leading European analytical CRO where he was also member of the board of directors. Between September 2011 and January 2014, Dr. Bedoret served as Engagement Manager at McKinsey & Company, focusing on bio-pharmaceutical projects. Through those experiences, he gained a strong expertise in biologicals, FDA and EMA regulations, as well as team management.
As the President of Masthercell Global of Orgenesis Inc, the total compensation of Denis Bedoret at Orgenesis Inc is $345,725. There are 4 executives at Orgenesis Inc getting paid more, with Vered Caplan having the highest compensation of $1,577,660.
Denis Bedoret is 39, he's been the President of Masthercell Global of Orgenesis Inc since 2019. There are 12 older and no younger executives at Orgenesis Inc. The oldest executive at Orgenesis Inc is Prof. Sarah Ferber Ph.D., 67, who is the Founder & Chief Scientific Officer.
Denis's mailing address filed with the SEC is C/O ORGENESIS INC., 20271 GOLDENROD LANE, GERMANTOWN, MD, 20876.
Over the last 12 years, insiders at Orgenesis Inc have traded over $4,872,134 worth of Orgenesis Inc stock and bought 375,420 units worth $216,187 . The most active insiders traders include Sca Theodorus, Ii Sa Theodorus, and Olivier Belenger. On average, Orgenesis Inc executives and independent directors trade stock every 263 days with the average trade being worth of $1,118,704. The most recent stock trade was executed by Victor Miller on 1 April 2024, trading 25,000 units of ORGS stock currently worth $12,500.
orgenesis inc (orgs) is a medical device company located in 21 sparrow cir, white plains, new york, united states.
Orgenesis Inc executives and other stock owners filed with the SEC include: